Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L8TN
|
|||
Former ID |
DIB003958
|
|||
Drug Name |
BU-4514N
|
|||
Synonyms |
BU-4514N; BU 4514N; AC1Q6BPU; AC1L4UFU; SCHEMBL194669; 4-[(2-{2-[(5-amino-6-methyltetrahydro-2h-pyran-2-yl)oxy]propyl}-1,3,6-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)carbonyl]-5-hydroxy-1,2-dihydro-3h-pyrrol-3-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Terminated | [1] | |
Company |
Bristol-Myers Squibb Co
|
|||
Structure |
Download2D MOL |
|||
Formula |
C27H42N2O5
|
|||
Canonical SMILES |
CC1CCC2C(C1)C=C(C(C2(C)C(=C3C(=O)CNC3=O)O)CC(C)OC4CCC(C(O4)C)N)C
|
|||
InChI |
1S/C27H42N2O5/c1-14-6-7-19-18(10-14)11-15(2)20(12-16(3)33-23-9-8-21(28)17(4)34-23)27(19,5)25(31)24-22(30)13-29-26(24)32/h11,14,16-21,23,31H,6-10,12-13,28H2,1-5H3,(H,29,32)/b25-24-
|
|||
InChIKey |
NKWRHFUPAYVQCE-IZHYLOQSSA-N
|
|||
CAS Number |
CAS 151013-39-7
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Low-affinity nerve growth factor receptor (NGFR) | Target Info | Modulator | [2] |
KEGG Pathway | Ras signaling pathway | |||
Rap1 signaling pathway | ||||
Cytokine-cytokine receptor interaction | ||||
PI3K-Akt signaling pathway | ||||
Neurotrophin signaling pathway | ||||
Transcriptional misregulation in cancer | ||||
Pathway Interaction Database | p75(NTR)-mediated signaling | |||
Neurotrophic factor-mediated Trk receptor signaling | ||||
Reactome | Axonal growth inhibition (RHOA activation) | |||
NRAGE signals death through JNK | ||||
p75NTR negatively regulates cell cycle via SC1 | ||||
Regulated proteolysis of p75NTR | ||||
NADE modulates death signalling | ||||
NRIF signals cell death from the nucleus | ||||
p75NTR recruits signalling complexes | ||||
NF-kB is activated and signals survival | ||||
Axonal growth stimulation | ||||
WikiPathways | Spinal Cord Injury | |||
BDNF signaling pathway | ||||
Signalling by NGF |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005173) | |||
REF 2 | A new neuritogenetic compound BU-4514N produced by Microtetraspora sp. J Antibiot (Tokyo). 1993 Jun;46(6):875-83. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.